News - Appointments

Mark Dawson joins advisory board at Storm Therapeutics

Read more

Bo Jesper Hansen becomes chair of Ablynx

Read more

Prof Eric Vivier becomes CSO at Innate Pharma

Read more

Michael Bogenstaetter becomes CBO at Targovax

Read more

Paul Stead becomes head of business development at Adaptimmune

Read more

Laura Wade-Gery becomes non-executive director at Immunocore

Read more

Gérard Tardy joins board of OSE Immunotherapeutics

Read more

Tomas Navratil becomes head of development at Nicox

Read more

Michael Schmelmer joins BI board of directors

Read more

Sally Ann Forsyth to lead Stevenage Bioscience Catalyst

Read more